166 related articles for article (PubMed ID: 36418766)
21. Dexmedetomidine Mitigates Microglia-Mediated Neuroinflammation through Upregulation of Programmed Cell Death Protein 1 in a Rat Spinal Cord Injury Model.
He H; Zhou Y; Zhou Y; Zhuang J; He X; Wang S; Lin W
J Neurotrauma; 2018 Nov; 35(21):2591-2603. PubMed ID: 29665726
[TBL] [Abstract][Full Text] [Related]
22. Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor.
Sha J; Zhang H; Zhao Y; Feng X; Hu X; Wang C; Song M; Fan H
Toxicol Appl Pharmacol; 2019 Feb; 364():144-152. PubMed ID: 30597158
[TBL] [Abstract][Full Text] [Related]
23. The Pathway of Let-7a-1/2-3p and HMGB1 Mediated Dexmedetomidine Inhibiting Microglia Activation in Spinal Cord Ischemia-Reperfusion Injury Mice.
Ha Sen Ta Na ; Nuo M; Meng QT; Xia ZY
J Mol Neurosci; 2019 Sep; 69(1):106-114. PubMed ID: 31190218
[TBL] [Abstract][Full Text] [Related]
24. Effects of dexmedetomidine on lipopolysaccharide-induced acute kidney injury in rats and mitochondrial function in cell culture.
Kiyonaga N; Moriyama T; Kanmura Y
Biomed Pharmacother; 2020 May; 125():109912. PubMed ID: 32014689
[TBL] [Abstract][Full Text] [Related]
25. Activation of α2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injury.
Chen JH; Yu GF; Jin SY; Zhang WH; Lei DX; Zhou SL; Song XR
Int J Clin Exp Pathol; 2015; 8(9):10752-9. PubMed ID: 26617786
[TBL] [Abstract][Full Text] [Related]
26. Dexmedetomidine Preconditioning Protects Rats from Renal Ischemia-Reperfusion Injury Accompanied with Biphasic Changes of Nuclear Factor-Kappa B Signaling.
Bao N; Tang B; Wang J
J Immunol Res; 2020; 2020():3230490. PubMed ID: 32377532
[TBL] [Abstract][Full Text] [Related]
27. [The protective effect of alpha-2 adrenergic agonist on cranial nerve in rats with brain injury].
Qiu YS; Jia YP; Xu Q
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2246-50. PubMed ID: 27480658
[TBL] [Abstract][Full Text] [Related]
28. Effect of dexmedetomidine on brain edema and neurological outcomes in surgical brain injury in rats.
Benggon M; Chen H; Applegate R; Martin R; Zhang JH
Anesth Analg; 2012 Jul; 115(1):154-9. PubMed ID: 22584551
[TBL] [Abstract][Full Text] [Related]
29. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.
Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH
Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299
[TBL] [Abstract][Full Text] [Related]
30. Dexmedetomidine Reduces the Lidocaine-Induced Neurotoxicity by Inhibiting Inflammasome Activation and Reducing Pyroptosis in Rats.
Ding XD; Cao YY; Li L; Zhao GY
Biol Pharm Bull; 2021; 44(7):902-909. PubMed ID: 34193687
[TBL] [Abstract][Full Text] [Related]
31. CD200R Is Involved in the Anti-inflammatory Effect of Dexmedetomidine in Lipopolysaccharide-Stimulated Microglia.
Zhang X; Cui J; Qian H; Wang B; Yan F; Zhao Z
Inflammation; 2020 Oct; 43(5):1707-1715. PubMed ID: 32394288
[TBL] [Abstract][Full Text] [Related]
32. Dexmedetomidine alleviates non-ventilation associated lung injury via modulating immunology phenotypes of macrophages.
Shen Q; Xu G; Liu J; Wang L; Zhou Y; Yu Y; Lv C; Liu X
Life Sci; 2020 Oct; 259():118249. PubMed ID: 32798558
[TBL] [Abstract][Full Text] [Related]
33. Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4/MyD88/NF-κB/iNOS signaling pathway.
Jin YH; Li ZT; Chen H; Jiang XQ; Zhang YY; Wu F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):5020-5025. PubMed ID: 31210339
[TBL] [Abstract][Full Text] [Related]
34. Dexmedetomidine attenuates lipopolysaccharide-induced inflammation through macrophageal IL-10 expression following α7 nAchR activation.
Han QQ; Li XY; Wang YX
Int Immunopharmacol; 2022 Aug; 109():108920. PubMed ID: 35691275
[TBL] [Abstract][Full Text] [Related]
35. Electroacupuncture regulates microglial polarization via inhibiting NF-κB/COX2 pathway following traumatic brain injury.
Zhang XH; Cui H; Zheng SM; Lu Y; Yuan HW; Zhang L; Wang HH; Du RS
Brain Res; 2023 Nov; 1818():148516. PubMed ID: 37562566
[TBL] [Abstract][Full Text] [Related]
36. Anti-Inflammatory Action of Dexmedetomidine on Human Microglial Cells.
Yamazaki S; Yamaguchi K; Someya A; Nagaoka I; Hayashida M
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077505
[TBL] [Abstract][Full Text] [Related]
37. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
[TBL] [Abstract][Full Text] [Related]
38. The therapeutic effect of dexmedetomidine on protection from renal failure via inhibiting KDM5A in lipopolysaccharide-induced sepsis of mice.
Liu Y; Yu Y; Zhang J; Wang C
Life Sci; 2019 Dec; 239():116868. PubMed ID: 31682847
[TBL] [Abstract][Full Text] [Related]
39. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
Liu J; Huang X; Hu S; He H; Meng Z
Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
[TBL] [Abstract][Full Text] [Related]
40. Dexmedetomidine Inhibits Inflammation to Alleviate Early Neuronal Injury via TLR4/NF-κB Pathway in Rats with Traumatic Brain Injury.
Huang GR; Hao FG
Crit Rev Eukaryot Gene Expr; 2021; 31(1):41-47. PubMed ID: 33639054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
